Item 8.01. Other Events.
As previously announced, a special meeting of stockholders of LifePoint Health, Inc. (the Company) will be held on Monday,
October 29, 2018, at 9:00 a.m., Central Time, at the LifePoint Health Support Center, 330 Seven Springs Way, Brentwood, Tennessee 37027. The special meeting also will be broadcast live on the Companys website,
www.LifePointHealth.net, in the Investor Relations section.
Additional Information and Where to Find It
This communication relates to the proposed merger transaction involving the Company. In connection with the proposed merger, the Company has
filed a proxy statement and other relevant documents with the Securities and Exchange Commission (the SEC) and first mailed the proxy statement to its stockholders on September 27, 2018. This communication is not a substitute for
the proxy statement or any other document that the Company has filed with the SEC or sent to its stockholders in connection with the proposed merger. BEFORE MAKING ANY VOTING DECISION, STOCKHOLDERS OF THE COMPANY ARE URGED TO READ ALL RELEVANT
DOCUMENTS FILED WITH THE SEC, INCLUDING THE PROXY STATEMENT, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain the proxy statement and
other documents filed by the Company with the SEC (when available) free of charge at the SECs website, http://www.sec.gov, and the Companys website, www.lifepointhealth.net.
Participants in the Solicitation
The
Company and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the holders of the Companys common stock in respect of the proposed transaction. Information about the directors and
executive officers of the Company is set forth in the Companys Annual Report on
Form 10-K for
the year ended December 31, 2017, filed with the SEC on February 23, 2018, and proxy
statement for its 2018 annual meeting of stockholders, filed with the SEC on April 25, 2018. Additional information regarding potential participants in the proxy solicitation and a description of their direct and indirect interests, by security
holdings or otherwise, is contained in the proxy statement and may be contained in other relevant documents to be filed by the Company with the SEC in respect of the proposed transaction.
Forward Looking Statements
This
communication contains certain information, including statements as to the expected timing, completion and effects of the proposed merger involving the Company, which may constitute forward-looking statements within the meaning of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, and actual results may differ materially. Such forward looking statements include, among others, statements
about the benefits of the proposed transaction, including future financial and operating results, plans, objectives, expectations for the Company and other statements that are not historical facts. Such statements are based on the current beliefs
and expectations of the management of the Company and are subject to significant risks and uncertainties outside of the Companys control. These risks and uncertainties include the possibility that the anticipated benefits from the proposed
transaction will not be realized, or will not be realized within the expected time periods; the occurrence of any event, change or other circumstances that could give rise to termination of the proposed transaction agreement; the failure of the
Companys stockholders to adopt the Agreement and Plan of Merger providing for the proposed transaction; operating costs, loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees,
customers or suppliers) may be greater than expected following the announcement of the proposed transaction; the retention of certain key employees at the Company; risks associated with the disruption of managements attention from ongoing
business operations due to the proposed transaction; the inability to obtain necessary regulatory approvals of the proposed transaction or the receipt of such approvals subject to conditions that are not anticipated; the risk that a condition to
closing the transaction may not be satisfied on a timely basis or at all; the risk that the proposed transaction fails to close for any other reason; the outcome of any legal proceedings related to the proposed transaction; the parties ability
to meet expectations regarding the timing and completion of the proposed transaction; the impact of the proposed transaction on the Companys credit rating; and other risks